Related references
Note: Only part of the references are listed.Innate and acquired immune surveillance in the postdissemination phase of metastasis
Hugo Gonzalez et al.
FEBS JOURNAL (2018)
MSK1 regulates luminal cell differentiation and metastatic dormancy in ER+ breast cancer
Sylwia Gawrzak et al.
NATURE CELL BIOLOGY (2018)
Circulating and disseminated tumor cells: harbingers or initiators of metastasis?
Arko Dasgupta et al.
MOLECULAR ONCOLOGY (2017)
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
Hongchao Pan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Current approaches for avoiding the limitations of circulating tumor cells detection methods-implications for diagnosis and treatment of patients with solid tumors
Artur Kowalik et al.
TRANSLATIONAL RESEARCH (2017)
Oestrogen receptor positive breast cancer metastasis to bone: inhibition by targeting the bone microenvironment in vivo
I. Holen et al.
CLINICAL & EXPERIMENTAL METASTASIS (2016)
Murine Oncostatin M Acts via Leukemia Inhibitory Factor Receptor to Phosphorylate Signal Transducer and Activator of Transcription 3 (STAT3) but Not STAT1, an Effect That Protects Bone Mass
Emma C. Walker et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Estrogen Receptor Status Predicts Late-Onset Skeletal Recurrence in Breast Cancer Patients
Hyun Ho Han et al.
MEDICINE (2016)
Early dissemination seeds metastasis in breast cancer
Hedayatollah Hosseini et al.
NATURE (2016)
Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the, bone marrow
Rachelle W. Johnson et al.
NATURE CELL BIOLOGY (2016)
Novel ERα positive breast cancer model with estrogen independent growth in the bone microenvironment
Aude-Helene Capietto et al.
ONCOTARGET (2016)
The role of membrane ERα signaling in bone and other major estrogen responsive tissues
K. L. Gustafsson et al.
SCIENTIFIC REPORTS (2016)
Bone metastasis: the importance of the neighbourhood
Peter I. Croucher et al.
NATURE REVIEWS CANCER (2016)
Cancer Cell Colonisation in the Bone Microenvironment
Casina Kan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Adaptive Stress Responses During Tumor Metastasis and Dormancy
Daniela Senft et al.
TRENDS IN CANCER (2016)
Retrospective analysis of metastatic behaviour of breast cancer subtypes
C. Dilara Savci-Heijink et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
The Osteogenic Niche Promotes Early-Stage Bone Colonization of Disseminated Breast Cancer Cells
Hai Wang et al.
CANCER CELL (2015)
Mammary gland development: cell fate specification, stem cells and the microenvironment
Jamie L. Inman et al.
DEVELOPMENT (2015)
Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells
Devon A. Lawson et al.
NATURE (2015)
HIF targets in bone remodeling and metastatic disease
Rachelle W. Johnson et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche
Michelle A. Lawson et al.
NATURE COMMUNICATIONS (2015)
Low Dose, Low Cost Estradiol Pellets Can Support MCF-7 Tumour Growth in Nude Mice without Bladder Symptoms
Genevieve Dall et al.
JOURNAL OF CANCER (2015)
T Lymphocytes Restrain Spontaneous Metastases in Permanent Dormancy
Irene Romero et al.
CANCER RESEARCH (2014)
UThe Primary Function of gp130 Signaling in Osteoblasts Is To Maintain Bone Formation and Strength, Rather Than Promote Osteoclast Formation
Rachelle W. Johnson et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Mechanisms of disseminated cancer cell dormancy: an awakening field
Maria Soledad Sosa et al.
NATURE REVIEWS CANCER (2014)
Luminal breast cancer metastases and tumor arousal from dormancy are promoted by direct actions of estradiol and progesterone on the malignant cells
Ndiya Ogba et al.
BREAST CANCER RESEARCH (2014)
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Min Yu et al.
SCIENCE (2013)
Luminal breast cancer metastasis is dependent on estrogen signaling
Vidya Ganapathy et al.
CLINICAL & EXPERIMENTAL METASTASIS (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker
Dahu Chen et al.
NATURE MEDICINE (2012)
Dormancy Signatures and Metastasis in Estrogen Receptor Positive and Negative Breast Cancer
Ryung S. Kim et al.
PLOS ONE (2012)
Models of Bone Metastasis
J. Preston Campbell et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2012)
TGF-β Promotion of Gli2-Induced Expression of Parathyroid Hormone-Related Protein, an Important Osteolytic Factor in Bone Metastasis, Is Independent of Canonical Hedgehog Signaling
Rachelle W. Johnson et al.
CANCER RESEARCH (2011)
Distinct stem cells contribute to mammary gland development and maintenance
Alexandra Van Keymeulen et al.
NATURE (2011)
Cancer to bone: a fatal attraction
Katherine N. Weilbaecher et al.
NATURE REVIEWS CANCER (2011)
Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma
Jo Eyles et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Molecular Stratification of Triple-Negative Breast Cancers
Charles M. Perou
ONCOLOGIST (2010)
Hydronephrosis and Urine Retention in Estrogen-Implanted Athymic Nude Mice
G. Gakhar et al.
VETERINARY PATHOLOGY (2009)
Systemic spread is an early step in breast cancer
Yves Huesemann et al.
CANCER CELL (2008)
Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton
Dalit Barkan et al.
CANCER RESEARCH (2008)
Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy
Christine M. Fillmore et al.
BREAST CANCER RESEARCH (2008)
Models, mechanisms and clinical evidence for cancer dormancy
Julio A. Aguirre-Ghiso
NATURE REVIEWS CANCER (2007)
Clinical features of metastatic bone disease and risk of skeletal morbidity
Robert E. Coleman
CLINICAL CANCER RESEARCH (2006)
Metastatic bone disease: clinical features, pathophysiology and treatment strategies
RE Coleman
CANCER TREATMENT REVIEWS (2001)
Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.
S Braun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
